1. Home
  2. PRTA vs HCKT Comparison

PRTA vs HCKT Comparison

Compare PRTA & HCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • HCKT
  • Stock Information
  • Founded
  • PRTA 2012
  • HCKT 1991
  • Country
  • PRTA Ireland
  • HCKT United States
  • Employees
  • PRTA N/A
  • HCKT N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • HCKT Professional Services
  • Sector
  • PRTA Health Care
  • HCKT Consumer Discretionary
  • Exchange
  • PRTA Nasdaq
  • HCKT Nasdaq
  • Market Cap
  • PRTA 472.1M
  • HCKT 545.3M
  • IPO Year
  • PRTA N/A
  • HCKT 1998
  • Fundamental
  • Price
  • PRTA $9.92
  • HCKT $18.61
  • Analyst Decision
  • PRTA Buy
  • HCKT Strong Buy
  • Analyst Count
  • PRTA 9
  • HCKT 3
  • Target Price
  • PRTA $13.14
  • HCKT $29.67
  • AVG Volume (30 Days)
  • PRTA 785.0K
  • HCKT 184.8K
  • Earning Date
  • PRTA 11-11-2025
  • HCKT 11-04-2025
  • Dividend Yield
  • PRTA N/A
  • HCKT 2.58%
  • EPS Growth
  • PRTA N/A
  • HCKT N/A
  • EPS
  • PRTA N/A
  • HCKT 0.59
  • Revenue
  • PRTA $10,341,000.00
  • HCKT $309,265,000.00
  • Revenue This Year
  • PRTA N/A
  • HCKT $2.33
  • Revenue Next Year
  • PRTA $602.32
  • HCKT $4.84
  • P/E Ratio
  • PRTA N/A
  • HCKT $31.45
  • Revenue Growth
  • PRTA N/A
  • HCKT 3.98
  • 52 Week Low
  • PRTA $4.32
  • HCKT $18.38
  • 52 Week High
  • PRTA $18.88
  • HCKT $34.02
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 55.31
  • HCKT 35.57
  • Support Level
  • PRTA $9.98
  • HCKT $18.38
  • Resistance Level
  • PRTA $10.90
  • HCKT $19.44
  • Average True Range (ATR)
  • PRTA 0.47
  • HCKT 0.40
  • MACD
  • PRTA -0.06
  • HCKT 0.04
  • Stochastic Oscillator
  • PRTA 23.93
  • HCKT 27.48

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About HCKT Hackett Group Inc (The).

The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.

Share on Social Networks: